Molecular pathogenesis and management strategies of ectopia lentis

Eye (Basingstoke)

Volumn 28, Issue 2, 2014, Pages 162-168

  Chandra, A ^a,b   Charteris, D ^b  

^a ROYAL VICTORIAN EYE AND EAR HOSPITAL   (Australia)

^b MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

ectopia lentis; Marfan syndrome; vitreolensectomy

Indexed keywords

A DISINTEGRIN AND METALLOPROTEINASE WITH THROMBOSPONDIN MOTIFS LIKE PROTEIN 4; FIBRILLIN 1; FIBRILLIN 2; FIBRILLIN 3; LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN; LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN 2; METALLOPROTEINASE; SCLEROPROTEIN; TRANSCRIPTION FACTOR PAX6; UNCLASSIFIED DRUG;

APHAKIA; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE INHERITANCE; CATARACTOGENESIS; CILIARY DISK; CONTACT LENS; ECTOPIA LENTIS; FIBER; HOMOCYSTINURIA; LENS; LENS SUBLUXATION; LENSECTOMY; MARFAN SYNDROME; MISSENSE MUTATION; MOLECULAR PATHOLOGY; NONSENSE MUTATION; PARS PLANA LENSECTOMY; PHACOEMULSIFICATION; PHENOTYPE; RETINA DETACHMENT; SPECTACLES; VITRECTOMY; VITREORETINOPATHY; WEILL MARCHESANI SYNDROME;

ADAM PROTEINS; CONTACT LENSES; ECTOPIA LENTIS; EYEGLASSES; HUMANS; MARFAN SYNDROME; MICROFILAMENT PROTEINS; PHACOEMULSIFICATION;

EID: 84894131219     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2013.274     Document Type: Article

References (78)

1. Karl Stellwag von Carion. BMJ 1904; 2(2293): 1615-1616.
2. Williams E. Rare cases, with practical remarks. Trans Am Ophthalmol Soc 1875; 2: 291-301.
3. Streeten BW. The zonular insertion: a scanning electron microscopic study. Invest Ophthalmol Vis Sci 1977; 16(4): 364-375.
4. Traboulsi EI, Whittum-Hudson JA, Mir SH, Maumenee IH. Microfibril abnormalities of the lens capsule in patients with Marfan syndrome and ectopia lentis. Ophthalmic Genet 2000; 21(1): 9-15.
5. Robert B, Szigeti M, Derouette JC, Robert L. Studies on the nature of the 'microfibrillar' component of elastic fibers. Eur J Biochem 1971; 21(4): 507-516.
6. Biery NJ, Eldadah ZA, Moore CS, Stetten G, Spencer F, Dietz HC. Revised genomic organization of FBN1 and significance for regulated gene expression. Genomics 1999; 56(1): 70-77.
7. Robinson PN, Godfrey M. Marfan Syndrome: A Primer for Clinicians and Scientists. Landes Bioscience/Eurekah.com: Georgetown, TX, USA, 2004.
8. Yuan X, Downing AK, Knott V, Handford PA. Solution structure of the transforming growth factor beta-binding protein-like module, a domain associated with matrix fibrils. Embo J 1997; 16(22): 6659-6666.
9. Zhang H, Hu W, Ramirez F. Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils. J Cell Biol 1995; 129(4): 1165-1176.
10. Davis EC, Roth RA, Heuser JE, Mecham RP. Ultrastructural properties of ciliary zonule microfibrils. J Struct Biol 2002; 139(2): 65-75.
11. Werneck CC, Trask BC, Broekelmann TJ, Trask TM, Ritty TM, Segade F et al. Identification of a major microfibril-associated glycoprotein-1-binding domain in fibrillin-2. J Biol Chem 2004; 279(22): 23045-23051.
12. Eldadah ZA, Brenn T, Furthmayr H, Dietz HC. Expression of a mutant human fibrillin allele upon a normal human or murine genetic background recapitulates a Marfan cellular phenotype. J Clin Invest 1995; 95(2): 874-880.
13. Maumenee IH. The eye in the Marfan syndrome. Trans Am Ophthalmol Soc 1981; 79: 684-733.
14. Loeys BL, Dietz HC, Braverman AC, Callewaert BL, De Backer J, Devereux RB et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet 2010; 47(7): 476-485.
15. Nemet AY, Assia EI, Apple DJ, Barequet IS. Current concepts of ocular manifestations in Marfan syndrome. Surv Ophthalmol 2006; 51(6): 561-575.
16. Faivre L, Collod-Beroud G, Loeys BL, Child A, Binquet C, Gautier E et al. Effect of mutation type and location on clinical outcome in 1, 013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study. Am J Hum Genet 2007; 81(3): 454-466.
17. Faivre L, Collod-Beroud G, Callewaert B, Child A, Loeys BL, Binquet C et al. Pathogenic FBN1 mutations in 146 adults not meeting clinical diagnostic criteria for Marfan syndrome: further delineation of type 1 fibrillinopathies and focus on patients with an isolated major criterion. Am J Med Genet A 2009; 149A(5): 854-860.
18. Trask TM, Ritty TM, Broekelmann T, Tisdale C, Mecham RP. N-terminal domains of fibrillin 1 and fibrillin 2 direct the formation of homodimers: a possible first step in microfibril assembly. Biochem J 1999; 340(Pt 3): 693-701.
19. Mir S, Wheatley HM, Hussels IE, Whittum-Hudson JA, Traboulsi EI. A comparative histologic study of the fibrillin microfibrillar system in the lens capsule of normal subjects and subjects with Marfan syndrome. Invest Ophthalmol Vis Sci 1998; 39(1): 84-93.
20. Ganesh A, Smith C, Chan W, Unger S, Quercia N, Godfrey M et al. Immunohistochemical evaluation of conjunctival fibrillin-1 in Marfan syndrome. Arch Ophthalmol 2006; 124(2): 205-209.
21. Kielty CM, Davies SJ, Phillips JE, Jones CJ, Shuttleworth CA, Charles SJ. Marfan syndrome: fibrillin expression and microfibrillar abnormalities in a family with predominant ocular defects. J Med Genet 1995; 32(1): 1-6.
22. Fuchs J, Rosenberg T. Congenital ectopia lentis. A Danish national survey. Acta Ophthalmol Scand 1998; 76(1): 20-26.
23. Chandra A. Isolated Ectopia Lentis. Orphanet Encyclopedia. Available at http://www.orpha.net/consor/cgi-bin/OC-Exp.php?Lng=EN&Expert=1885.
24. Vanita V, Singh JR, Singh D, Varon R, Robinson PN, Sperling K. A recurrent FBN1 mutation in an autosomal dominant ectopia lentis family of Indian origin. Mol Vis 2007; 13: 2035-2040.
25. Zhao JH, Jin TB, Liu QB, Chen C, Hu HT. Ophthalmic findings in a family with early-onset isolated ectopia lentis and the p.Arg62Cys mutation of the fibrillin-1 gene (FBN1). Ophthalmic Genet 2012; 34: 21-26.
26. Ades LC, Holman KJ, Brett MS, Edwards MJ, Bennetts B. Ectopia lentis phenotypes and the FBN1 gene. Am J Med Genet A 2004; 126A(3): 284-289.
27. Edwards MJ, Challinor CJ, Colley PW, Roberts J, Partington MW, Hollway GE et al. Clinical and linkage study of a large family with simple ectopia lentis linked to FBN1. Am J Med Genet 1994; 53(1): 65-71.
28. Loeys B, Nuytinck L, Delvaux I, De Bie S, De Paepe A. Genotype and phenotype analysis of 171 patients referred for molecular study of the fibrillin-1 gene FBN1 because of suspected Marfan syndrome. Arch Intern Med 2001; 161(20): 2447-2454.
29. Yang G, Chu M, Zhai X, Zhao J. A novel FBN1 mutation in a Chinese family with isolated ectopia lentis. Mol Vis 2012; 18: 945-950.
30. Li H, Qu W, Meng B, Zhang S, Yang T, Huang S et al. Identification and study of a FBN1 gene mutation in a Chinese family with ectopia lentis. Mol Vis 2012; 18: 504-511.
31. Pepe G, Lapini I, Evangelisti L, Attanasio M, Giusti B, Lucarini L et al. Is ectopia lentis in some cases a mild phenotypic expression of Marfan syndrome? Need for a long-term follow-up. Mol Vis 2007; 13: 2242-2247.
32. Zadeh N, Bernstein JA, Niemi AK, Dugan S, Kwan A, Liang D et al. Ectopia lentis as the presenting and primary feature in Marfan syndrome. Am J Med Genet A 2011; 155A(11): 2661-2668.
33. Falls HF, Cotterman CW. Genetic studies on ectopia lentis: a pedigree of simple ectopia of the lens. Arch Ophthalmol 1943; 30: 610-620.
34. Ruiz C, Rivas F, Villar-Calvo VM, Serrano-Lucas JI, Cantu JM. Familial simple ectopia lentis. A probable autosomal recessive form. Ophthalmic Paediatr Genet 1986; 7(2): 81-84.
35. Al-Salem M. Autosomal recessive ectopia lentis in two Arab family pedigrees. Ophthalmic Paediatr Genet 1990; 11(2): 123-127.
36. Ahram D, Sato TS, Kohilan A, Tayeh M, Chen S, Leal S et al. A homozygous mutation in ADAMTSL4 causes autosomal-recessive isolated ectopia lentis. Am J Hum Genet 2009; 84(2): 274-278.
37. Greene VB, Stoetzel C, Pelletier V, Perdomo-Trujillo Y, Liebermann L, Marion V et al. Confirmation of ADAMTSL4 mutations for autosomal recessive isolated bilateral ectopia lentis. Ophthalmic Genet 2010; 31(1): 47-51.
38. Aragon-Martin JA, Ahnood D, Charteris DG, Saggar A, Nischal KK, Comeglio P et al. Role of ADAMTSL4 mutations in FBN1 mutation-negative ectopia lentis patients. Hum Mutat 2010; 31(8): E1622-E1631.
39. Neuhann TM, Artelt J, Neuhann TF, Tinschert S, Rump A. A homozygous microdeletion within ADAMTSL4 in patients with isolated ectopia lentis: evidence of a founder mutation. Invest Ophthalmol Vis Sci 2011; 52(2): 695-700.
40. Chandra A, Aragon-Martin JA, Hughes K, Gati S, Reddy MA, Deshpande C et al. A genotype-phenotype comparison of ADAMTSL4 and FBN1 in isolated ectopia lentis. Invest Ophthalmol Vis Sci 2012; 53(8): 4889-4896.
41. Christensen AE, Fiskerstrand T, Knappskog PM, Boman H, Rodahl E. A novel ADAMTSL4 mutation in autosomal recessive ectopia lentis et pupillae. Invest Ophthalmol Vis Sci 2010; 51(12): 6369-6373.
42. Sharifi Y, Tjon-Fo-Sang MJ, Cruysberg JR, Maat-Kievit AJ. Ectopia lentis et pupillae in four generations caused by novel mutations in the ADAMTSL4 gene. Br J Ophthalmol 2013; 97: 583-587.
43. Gabriel LA, Wang LW, Bader H, Ho JC, Majors AK, Hollyfield JG et al. ADAMTSL4, a secreted glycoprotein widely distributed in the eye, binds fibrillin-1 microfibrils and accelerates microfibril biogenesis. Invest Ophthalmol Vis Sci 2012; 53(1): 461-469.
44. Chandra A, Jones M, Cottrill P, Eastlake K, Limb GA, Charteris DG. Gene expression and protein distribution of ADAMTSL-4 in human iris, choroid and retina. Br J Ophthalmol 2013; 97: 1208-1212.
45. Faivre L, Dollfus H, Lyonnet S, Alembik Y, Megarbane A, Samples J et al. Clinical homogeneity and genetic heterogeneity in Weill-Marchesani syndrome. Am J Med Genet A 2003; 123A(2): 204-207.
46. Faivre L, Gorlin RJ, Wirtz MK, Godfrey M, Dagoneau N, Samples JR et al. In frame fibrillin-1 gene deletion in autosomal dominant Weill-Marchesani syndrome. J Med Genet 2003; 40(1): 34-36.
47. Morales J, Al-Sharif L, Khalil DS, Shinwari JM, Bavi P, Al-Mahrouqi RA et al. Homozygous mutations in ADAMTS10 and ADAMTS17 cause lenticular myopia, ectopia lentis, glaucoma, spherophakia, and short stature. Am J Hum Genet 2009; 85(5): 558-568.
48. Dagoneau N, Benoist-Lasselin C, Huber C, Faivre L, Megarbane A, Alswaid A et al. ADAMTS10 mutations in autosomal recessive Weill-Marchesani syndrome. Am J Hum Genet 2004; 75(5): 801-806.
49. Tsilou E, MacDonald IM. Weill-Marchesani Syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, Adam MP (eds). GeneReviews. University of Washington: Seattle, WA, USA, 1993.
50. Khan AO, Aldahmesh MA, Al-Ghadeer H, Mohamed JY, Alkuraya FS. Familial spherophakia with short stature caused by a novel homozygous ADAMTS17 mutation. Ophthalmic Genet 2012; 33(4): 235-239.
51. Haji-Seyed-Javadi R, Jelodari-Mamaghani S, Paylakhi SH, Yazdani S, Nilforushan N, Fan JB et al. LTBP2 mutations cause Weill-Marchesani and Weill-Marchesani-like syndrome and affect disruptions in the extracellular matrix. Hum Mutat 2012; 33(8): 1182-1187.
52. Khan AO, Aldahmesh MA, Alkuraya FS. Congenital megalocornea with zonular weakness and childhood lens-related secondary glaucoma-a distinct phenotype caused by recessive LTBP2 mutations. Mol Vis 2011; 17: 2570-2579.
53. Harrison DA, Mullaney PB, Mesfer SA, Awad AH, Dhindsa H. Management of ophthalmic complications of homocystinuria. Ophthalmology 1998; 105(10): 1886-1890.
54. Burke JP, O'Keefe M, Bowell R, Naughten ER. Ocular complications in homocystinuria-early and late treated. Br J Ophthalmol 1989; 73(6): 427-431.
55. Edwards AO. Clinical features of the congenital vitreoretinopathies. Eye (Lond) 2008; 22(10): 1233-1242.
56. Knobloch WH, Layer JM. Retinal detachment and ecephalocele. J Pediat Ophthal 1971; 8: 181-184.
57. Sertie AL, Sossi V, Camargo AA, Zatz M, Brahe C, Passos-Bueno MR. Collagen XVIII, containing an endogenous inhibitor of angiogenesis and tumor growth, plays a critical role in the maintenance of retinal structure and in neural tube closure (Knobloch syndrome). Hum Mol Genet 2000; 9(13): 2051-2058.
58. Ponsioen TL, van Luyn MJ, van der Worp RJ, van Meurs JC, Hooymans JM, Los LI. Collagen distribution in the human vitreoretinal interface. Invest Ophthalmol Vis Sci 2008; 49(9): 4089-4095.
59. Fukai N, Eklund L, Marneros AG, Oh SP, Keene DR, Tamarkin L et al. Lack of collagen XVIII/endostatin results in eye abnormalities. Embo J 2002; 21(7): 1535-1544.
60. Khan AO, Aldahmesh MA, Noor J, Salem A, Alkuraya FS. Lens subluxation and retinal dysfunction in a girl with homozygous VSX2 mutation. Ophthalmic Genet 2013.
61. Liang L, Sandell JH. Focus on molecules: homeobox protein Chx10. Exp Eye Res 2008; 86(4): 541-542.
62. Jin C, Wang Q, Li J, Zhu Y, Shentu X, Yao K. A recurrent PAX6 mutation is associated with aniridia and congenital progressive cataract in a Chinese family. Mol Vis 2012; 18: 465-470.
63. Le Goff C, Cormier-Daire V. The ADAMTS(L) family and human genetic disorders. Hum Mol Genet 2011; 20(R2): R163-R167.
64. Apte SS. A disintegrin-like and metalloprotease (reprolysin-type) with thrombospondin type 1 motif (ADAMTS) superfamily: functions and mechanisms. J Biol Chem 2009; 284(46): 31493-31497.
65. Chandra A, Banerjee PJ, Charteris DG. Grading in ectopia lentis (GEL): a novel classification system. Br J Ophthalmol 2013; 97: 942-943.
66. Neely DE, Plager DA. Management of ectopia lentis in children. Ophthalmol Clin North Am 2001; 14(3): 493-499.
67. Hubbard AD, Charteris DG, Cooling RJ. Vitreolensectomy in Marfan's syndrome. Eye (Lond) 1998; 12(Pt 3a): 412-416.
68. Johnston RL, Charteris DG, Horgan SE, Cooling RJ. Combined pars plana vitrectomy and sutured posterior chamber implant. Arch Ophthalmol 2000; 118(7): 905-910.
69. Yang YF, Bunce C, Dart JK, Johnston RL, Charteris DG. Scleral-fixated posterior chamber intraocular lenses in non-vitrectomized eyes. Eye (Lond) 2006; 20(1): 64-70.
70. Vote BJ, Tranos P, Bunce C, Charteris DG, Da Cruz L. Long-term outcome of combined pars plana vitrectomy and scleral fixated sutured posterior chamber intraocular lens implantation. Am J Ophthalmol 2006; 141(2): 308-312.
71. Wagoner MD, Cox TA, Ariyasu RG, Jacobs DS, Karp CL. Intraocular lens implantation in the absence of capsular support: a report by the American Academy of Ophthalmology. Ophthalmology 2003; 110(4): 840-859.
72. Cleary C, Lanigan B, O'Keeffe M. Artisan iris-claw lenses for the correction of aphakia in children following lensectomy for ectopia lentis. Br J Ophthalmol 2012; 96(3): 419-421.
73. Dietz HC, Cutting GR, Pyeritz RE, Maslen CL, Sakai LY, Corson GM et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 1991; 352(6333): 337-339.
74. Kraus JP Komrower lecture. molecular basis of phenotype expression in homocystinuria. J Inherit Metab Dis 1994; 17(4): 383-390.
75. Desir J, Sznajer Y, Depasse F, Roulez F, Schrooyen M, Meire F et al. LTBP2 null mutations in an autosomal recessive ocular syndrome with megalocornea, spherophakia, and secondary glaucoma. Eur J Hum Genet 2010; 18(7): 761-767.
76. Kutz WE, Wang LW, Dagoneau N, Odrcic KJ, Cormier-Daire V, Traboulsi EI et al. Functional analysis of an ADAMTS10 signal peptide mutation in Weill-Marchesani syndrome demonstrates a long-range effect on secretion of the full-length enzyme. Hum Mutat 2008; 29(12): 1425-1434.
77. Aldahmesh MA, Alshammari MJ, Khan AO, Mohamed JY, Alhabib FA, Alkuraya FS. The syndrome of microcornea, myopic chorioretinal atrophy, and telecanthus (MMCAT) is caused by mutations in ADAMTS18. Hum Mutat 2013; 34(9): 1195-1199.
78. Peluso I, Conte I, Testa F, Dharmalingam G, Pizzo M, Collin RW et al. The ADAMTS18 gene is responsible for autosomal recessive early onset severe retinal dystrophy. Orphanet J Rare Dis 2013; 8(1): 16.